C erebral ischemia is a frequent complication after traumatic brain injury (TBI) (1, 2) . Posttraumatic cerebral ischemia (PTCI) is present in 90% of fatal cases, and in some is the only cause of death (1, 3) . Measures of cerebral oxygenation and perfusion are therefore of paramount importance in the management of TBI. Cerebral perfusion pressure is a major determinant of cerebral perfusion in the injured brain, and targeted cerebral perfusion pressure management is widely advocated for TBI patients (4) . However, the optimal cerebral perfusion pressure target remains elusive, and may vary substantially in different patients or in the same patient over time (4) . Hence, direct measurement of cerebral blood flow (CBF) plays a crucial role in the diagnosis of PTCI (5) . To our knowledge, the methodologic adequacy of studies from which currently used CBF thresholds in TBI have been derived has not been evaluated. We, therefore, systematically reviewed the medical literature to evaluate the evidence available on CBF thresholds and its methodologic adequacy in adults with TBI.
MATERIALS AND METHODS
The proposal of this systematic review of observational studies was submitted to the local institutional review board that, according to the Italian law, waived a formal approval.
Identification of Studies. Studies were identified by electronically searching Medline (January 1966 through June 2007), Embase (January 1982 through June 2007), and the Cochrane Library (January 1993 through June 2007). The following words were used both as text words and keywords: brain ischemia, cerebral ischemia, brain blood flow, cerebral blood flow, blood flow measurement, brain injury, brain trauma, head injury, and head trauma. The electronic search was complemented by cross-checking of reference lists of all relevant studies and contact with authors and experts in the field. Study selection was performed independently by two authors (MB, EB), and disagreements resolved through discussion with a third reviewer (NL).
Study Selection. Included were primary studies on adults with TBI in which CBF thresholds were evaluated and reported, and either follow-up brain computed tomography or magnetic resonance imaging (MRI) were used as diagnostic gold standards for diagnosing the finally infarcted area.
Data Extraction. Two reviewers (EB, MB) independently extracted the data and disagreements were resolved through discussion with a third author (NL). Study quality was assessed based on the Standards for Reporting of Diagnostic Accuracy (6) and the Quality Assessment of Studies of Diagnostic Accuracy included in Systematic Reviews (7). Information extracted included CBF thresholds; number of patients; study design; study population (demographics, Glasgow Coma Scale score); reference and index tests; independent and blind comparison between reference and index tests; coregistration of the reference and index test.
RESULTS
The whole process of inclusion and exclusion of studies is shown in Figure 1 .
Fifty-three out of 253 articles reviewed for inclusion were primary studies on CBF in adult patients with TBI.
Thirty-one studies were excluded because they did not evaluate the diagnostic performance of CBF measurement. In particular, 22 studies simply described CBF values observed in different types of posttraumatic brain lesions (e.g., brain edema, cerebral contusions) or in Background: Reduction of cerebral blood flow plays a crucial role in causing posttraumatic cerebral ischemia. However, the methodologic adequacy of studies from which currently used cerebral blood flow thresholds in traumatic brain injury have been derived has not been evaluated.
Objective: To systematically evaluate the evidence available on cerebral blood flow thresholds and its methodologic adequacy in adults with traumatic brain injury.
Methods: Included were primary studies on adults with traumatic brain injury in which cerebral blood flow thresholds were evaluated and reported, and follow-up brain computed tomography or magnetic resonance imaging was used as the gold standard for diagnosing the finally infarcted area.
Results: Among the 53 diagnostic studies identified, 31 did not report any threshold value, whereas 20 studies used thresholds derived from the literature, mainly animal or clinical studies on ischemic stroke. One study measured cerebral blood flow thresholds, but did not use accepted neuroradiological criteria for the diagnosis of posttraumatic cerebral ischemia. The remaining study fulfilled all methodologic inclusion criteria, but was restricted to 14 patients with severe traumatic brain injury and cerebral contusion. This study proposed a cerebral blood flow threshold of 15 mL/100 mL/min, with sensitivity and specificity of 43% and 95%, respectively.
Conclusions: Cerebral blood flow thresholds for the diagnosis of posttraumatic cerebral ischemia are based on weak evidence, and cannot be recommended. (Crit Care Med 2008; 36:3089 -3092) KEY WORDS: systematic review; cerebral blood flow; cerebral ischemia; cerebral infarction; traumatic brain injury particular conditions associated with TBI (e.g., anemia, hyperventilation), whereas nine studies evaluated the prognostic, rather than diagnostic, value of CBF measurement in predicting clinical outcomes (e.g., Glasgow Outcome Scale, mortality).
Twenty studies were further excluded because they evaluated the diagnostic performance of CBF using CBF thresholds derived from the literature. Table 1 shows the literature sources used, the majority of which indicates threshold values of 18 -20 mL/100 mL/min derived from either animal experiments (monkeys and pigs) or studies on carotid surgery in patients with acute ischemic stroke.
Only two studies were left, which evaluated CBF thresholds for PTCI (8, 9), one of which was further excluded because the diagnosis of PTCI was based on cerebral atrophy measured by ventricle size (8), which is not an accepted diagnostic criterion for PTCI. Details of the 52 studies excluded are available on request from the authors.
The only study included in the review was a retrospective cohort study of 14 consecutive patients with severe TBI (Glasgow Coma Scale score Յ8) and focal injury (cerebral contusion) (9). CBF measurement by positron emission tomography was obtained within 72 hrs of TBI (mean ϭ 46 hrs); the diagnostic gold standard was follow-up MRI at 3-18 months (mean ϭ 239 days) after injury. Index test (positron emission tomography-CBF) and reference test (follow-up MRI) were coregistered and comparison between the two tests was independent and blind. The authors reported a CBF threshold of 15 mL/100 mL/min for irreversible ischemic damage (cerebral infarction), which was obtained based on a cumulative probability function for voxels coming from lesion and nonlesion regions of interest of the brain. The sensitivity of this threshold (proportion of lesion voxels correctly classified) was 43%, and the specificity (proportion of nonlesion voxels correctly classified) was 95%. In the study population, where lesion voxels represented 4.3% of the entire supratentorial brain volume (i.e., prior probability of lesion of 4.3%), the positive predictive value was only 27%, whereas the negative predictive value was 96%. The authors also calculated positive and negative predictive values under the hypothetical scenario of a much higher prior probability of lesion, i.e., 50%, which might be more appropriate if the analysis is limited to pericontusional regions. In this scenario, the corresponding positive predictive value became 90% and the negative predictive value 63%.
DISCUSSION
This systematic review on CBF thresholds for the diagnosis of PTCI explored the literature published over the last 62 years, since the first method for measuring CBF in humans became available in 1945 (10). Among the 22 studies identified, which assessed the performance of CBF measurements in the diagnosis of PTCI, only two attempted to derive CBF thresholds. The other 20 studies adopted threshold values reported in the literature, which were mainly derived from studies performed in the 1970s and early 1980s in either animal models of acute ischemic stroke or humans with ischemia during carotid endarterectomy. However, translation of results from animal experiments to mankind can be difficult, as is the extrapolation of results from stroke studies to TBI. Although some pathophysiologic mechanisms are common to both the ischemic and traumatized brain-for example, the inflammatory response has detrimental effects in the acute phase and beneficial effects in the chronic phase of both conditions (11)differences between the two conditions remain substantial. In acute ischemic stroke, persistent CBF impairment eventually leads to neuronal death, particularly at the center of the ischemic focus, where cells die within minutes of ischemic onset. TBI involves a "primary" mechanical impact that abruptly disrupts the brain parenchyma with shearing and tearing of blood vessels and brain tissue. This, in turn, triggers a cascade of events characterized by activation of molecular and cellular responses that lead to "secondary" ischemic injury (5) . Cerebral metabolism is often reduced after TBI (1), because of the trauma itself or the associated use of sedatives, so that apparently low CBF, resulting from preserved flowmetabolism coupling, might indeed be normal. Conversely, excitotoxicity may lead to an increase in cerebral metabolism that is not met by apparently normal CBF. Both situations will alter the CBF threshold for tissue survival compared to ischemic stroke. Another important difference with ischemic stroke is that posttraumatic cerebral damage is often diffuse rather than focal. Because of these differences, deriving CBF ischemic thresholds for TBI from ischemic stroke is hardly justified. In addition, CBF thresholds for acute ischemic stroke are themselves based on weak evidence (12). The fact that only two diagnostic studies on CBF measurements did evaluate CBF thresholds suggests that the importance of the choice of the threshold, as well as its implications for the interpretation of indices of diagnostic performance, is under recognized. Sensitivity and specificity of a test, that is its capability to correctly classify diseased and nondiseased individuals, highly depend on the threshold value used to define positive and negative results so that a test can only be "good" if used with an appropriate threshold. For this reason, the most informative way of presenting the results of diagnostic studies is the receiver operating characteristic curve, where sensitivity and specificity are plotted for different threshold values.
Another crucial methodologic point of diagnostic studies is the need to compare the results of the test under evaluation with those of a recognized diagnostic gold standard. Only one study used an accepted gold standard (9). This might be partly explained by the lack of consensus on the imaging method(s) and criteria to diagnose PTCI "antemortem" (2) .
The only included study had a sample size of 14 patients (9). However, the power of the study is difficult to evaluate because the voxel, not the patient, was the unit of analysis. The pooled set of voxels was analyzed without accounting for the hierarchical nature of the data, where each voxel belongs to a certain brain region of interest within a certain patient. A more appropriate analysis would require the use of a three-level statistical model, which takes into account both the within-regions of interest and the within-patient correlation. The CBF threshold value of 15 mL/100 mL/ min for cerebral infarction was derived using the lower 95% confidence limit of CBF values in normal (noninfarcted) tissue. Such an approach implicitly favors specificity at the expense of sensitivity, as demon-strated by the results of the study (sensitivity ϭ 0.43; specificity ϭ 0.95). Hence, although tissue with CBF values below this threshold was highly likely to become infarcted, much lesion tissue would have value above this threshold. This means that the use of this threshold would lead to under-diagnose the presence of PTCI in patients with cerebral contusion, as acknowledged by the authors of the study.
PTCI is an extremely complex event (1), and it is unlikely that future studies would use CBF as the sole diagnostic test. Detection of the three components of PTCI, namely sustained global ischemia, transient diffuse ischemia, and sustained focal ischemia (1), depends on combined measurement of CBF and cerebral oxygen metabolism made sufficiently soon, sufficiently often, and with sufficient resolution to detect local impairments, respectively. However, the methodologic principles of good diagnostic studies remain the same, and future research evaluating a combination of diagnostic tests for PTCI should consider the results of this systematic review to avoid the limitations we found in the current literature.
At Sources used by those studies (n ϭ 20) that evaluated diagnostic performance of CBF based on thresholds values reported in the literature.
